Published in Am J Gastroenterol on May 01, 2016
Vitamin D and Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2016) 0.75
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr (2004) 8.48
Clinical practice. Vitamin D insufficiency. N Engl J Med (2011) 6.84
Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology (2011) 3.84
Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr (2004) 3.11
Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol (2013) 3.03
A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol (2003) 2.69
Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther (2010) 2.09
Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther (2013) 2.06
Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol (2008) 1.92
Geographical variation and incidence of inflammatory bowel disease among US women. Gut (2012) 1.85
Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dis (2013) 1.60
D-hormone and the immune system. J Rheumatol Suppl (2005) 1.34
Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study. Am J Gastroenterol (2016) 1.34
Review article: vitamin D and inflammatory bowel disease--established concepts and future directions. Aliment Pharmacol Ther (2012) 1.22
Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients. Clin Transl Gastroenterol (2013) 1.19
Vitamin D as a therapy for colitis: a systematic review. J Crohns Colitis (2012) 1.18
Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Aliment Pharmacol Ther (2014) 0.95
Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc (2013) 0.94
Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn's Disease. Am J Gastroenterol (2016) 0.75